One of the changes that CMS has added is a Health Equity Index (HEI) reward to its Stars program. The agency will use HEI data collected this year and next to calculate 2027 Star Ratings, so plans must capture member data on every measure included in the HEI.
Multiple changes by CMS to calculate risk adjustment factor (RAF) and quality of care scores are forcing health plan leaders to significantly revise their plans or risk lower reimbursements from government-sponsored programs.
Some of the risk model and Star Ratings changes for those programs (Medicare, Marketplace and Medicaid) and others are still being fine-tuned so the direct financial impact cannot yet be accurately predicted. One thing, however, is clear: Health plans should be taking steps now to update their policies, procedures and technology. Doing so will help plans avoid any revenue disruptions that might have negative consequences for the plan, its members and providers.
To manage the wide variety of CMS modifications, plan leaders must take a thoughtful, strategic approach by focusing on three areas: updating their systems to incorporate the new risk model scores, revising the Star Ratings program to factor in new CMS criteria, and reconfiguring data collection systems to comply with CMS Health Equity Index requirements.
CMS’s updates to RAF scores pose the biggest challenge because any errors by plans could have far-reaching consequences. CMS, which uses hierarchical condition category (HCC) coding to forecast future health costs, modified its risk adjustment model — from V24 to V28 — to ensure payments accurately reflect the cost of care. Some of the revisions included increasing the number of HCC categories (from 86 to 115), adding 268 diagnostic codes (ICD-10-CM codes), and eliminating 2,296 codes. Plans must update their systems and their data algorithms to reflect the changes, capture all qualified risk conditions, and fine tune their processes for the new model and rules being considered.
But there are also a few other factors at play. Many plans, for example, have built their own customized, internal risk models. Those models must be reconfigured to be consistent with V28. Also, V28 will be phased in over three years. This year, health plans will be reimbursed at a ratio of 67% for the V24 model and 33% for V28. In 2025, it flips to 67% for V28 and 33% for V24. In the third year, reimbursement will be paid using V28.
CMS expects lower risk scores as it transitions from V24 to V28, which in turn is expected to negatively impact plan revenue. How much will depend on the plan’s readiness and preparation. To navigate the changeover successfully, health plans should consider the following:
Even before the CMS changes to risk adjustment, health plans were already experiencing unexpected revenue decreases due to incomplete and inaccurate encounter information that reduces their risk profile. The changes will only make the compliance reporting process more complex.
The common root causes of inaccurate reporting are:
Organizations need a process in place to continually analyze and remediate common coding errors or oversights. A positive return can be realized by focusing strategic initiatives on the members, providers or codes with the greatest coding gaps.
Health plans, which are still reeling from the fallout of previous CMS revisions that led to lower Star Ratings, could see additional downward pressure on plan ratings. For the Star Year 2026 (plan year 2027), for example, CMS has recommended raising the hold harmless threshold to 5.0 Stars. It also suggested eliminating guardrails that are used to set cut points for non-Consumer Assessment of Healthcare Providers and Systems (CAHPS) measures.
Quality bonus payments tied to higher star ratings are a primary contributor to a plan’s revenue from the federal government. Plans earn around $45 per member per month in bonus payments (before rebates) when a plan has a 4.0 rating or higher. A dip in the rating translates into a material decline in revenue.
The challenge that plans face is that CMS is still working out the details on which measures will be dropped, which ones will be added, and how the changes will be calculated. Also, it will be some time before CMS offers training programs to plans and providers about the new reporting metrics and procedures. Fortunately, plans can preview their display measure data to monitor performance and help them prepare for future changes.
Meanwhile, here are two areas which plans should focus on to bolster plan performance and member care to protect or enhance Star Ratings:
To enhance care for enrollees with certain social risk factors, CMS has added a Health Equity Index (HEI) reward to its Stars program. The goal of the HEI initiative is to help achieve health equity for all Americans and reduce disparities among minority and underserved populations.
CMS will use HEI data collected this year and in 2025 to calculate 2027 Star Ratings, so plans must capture member data on every measure included in the HEI. CMS estimates, however, indicate that 75% of all 5.0-Star plan contracts could drop to 4.5 Stars when HEI data is included. To mitigate the risk of losing Star Ratings points, plans should consider the following:
Each one of these changes — risk adjustment models, Star Ratings revisions and HEI reporting — affects the other. Plans should take a holistic approach to organizational updates and keep in mind these four points:
The future is now. Plan leaders must be proactive and not reactive to the upcoming changes. By taking aggressive action, leaders will be better positioned to improve plan performance and member care in today’s dynamic operating environment.
Darren Ghanayem is a managing director of AArete.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen